Tulaven

Authorised

This medicine is authorised for use in the European Union

tulathromycin

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Tulaven : EPAR - Medicine overview

Reference Number: EMA/149613/2020

Product information

Tulaven : EPAR - Product information

Tulaven : EPAR - All authorised presentations

Product details

• Name of medicine:
  Tulaven
• Active substance:
  tulathromycin
• International non-proprietary name (INN) or common name:
  tulathromycin

Pharmacotherapeutic group

Antibacterials for systemic use

Authorisation details

• EMA product number:
  EMEA/V/C/005153
• Generic:

  This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Assessment history

Changes since initial authorisation of medicine

Tulaven : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Tulaven : EPAR - Public assessment report

Adopted Reference Number: EMA/94834/2020

CVMP summary of positive opinion for Tulaven

Adopted Reference Number: EMA/CVMP/50678/2020